PTC Therapeutics
PTCT
$32.08
Share price
12.29%
Change (1 day)
-41.82%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Total assets
Total assets on the balance sheet as of December 2023 : $1.89 B
According to PTC Therapeutics 's latest financial reports the company's total assets are $1.89 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
PTC Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.89 B | 11.14% |
| 2022-12-31 | $1.70 B | -11.99% |
| 2021-12-31 | $1.93 B | -12.24% |
| 2020-12-31 | $2.20 B | 36% |
| 2019-12-31 | $1.62 B | 45.08% |
| 2018-12-31 | $1.11 B | 185.77% |
| 2017-12-31 | $0.39 B | 45.41% |
| 2016-12-31 | $0.26 B | -26.26% |
| 2015-12-31 | $0.36 B | 9.62% |
| 2014-12-31 | $0.33 B | 119.36% |
| 2013-12-31 | $0.15 B | 1062.02% |
| 2012-12-31 | $13.07 M | -70.39% |
| 2011-12-31 | $44.14 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 4,876.21% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $22.73 B | 1,099.04% | 🇺🇸 USA |
 Xencor XNCR | $0.95 B | -49.74% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $3.26 B | 72.21% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.50 B | -73.30% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.62 B | -66.84% | 🇺🇸 USA |